Tramadol hcl 50 mg
amoxicillin 500 mg capsule
prednisone 20 mg price
tramadol 50mg high
בזק מהירות
portuguese-passport.online
darkon-portugali.com
איביי ישראל, אי ביי ישראל קניות
מאוחדת זימון תור, גוגל תרגם מאנגלית לעברית, מאוחדת טורים טלפון
מונוניט
турбофорекс отзывы
турбофорекс отзывы
baner

Outcomes

торговые сигналы бинарных опционов
алиэкспресс полная версия
как зарабатывать на олимп трейд
In the 2-year, United States clinical trial, the VisAbility™ Micro-Insert System appeared to demonstrate excellent visual outcomes, with almost 90% of eyes achieving a distance corrected near visual acuity (DCNVA) of 20/40 or better at 24 months post-op. Similar results were seen in a trial conducted outside of the United States, with 90% of patients achieving DCNVA of 20/40 or better at 12 months post-op.1

superior-outcomes-1

VisAbility Implant System—DCNVA 20/40 or Better1
DCNVA at 40cm

Reference
1. Data on file. Refocus Group, Inc.

*Data on file from protocol P-277-5 (IDE G970152) and protocols EU001/SPN001. Refocus Group, Inc. P 277-5 Study completion date July 30, 2015; SPN-001 Study completion date July 30, 2015; EU-001 Study completion date March 15, 2016